Back to search

Article

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?

2020-07-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>To investigate whether the reason to discontinue the first TNF inhibitor (TNFi) affects the response to a second TNFi in axial spondyloartrhtis (axSpA).<bold>Methods: </bold>Patients with axSpA from the Rheumatic Diseases Portuguese Register (ReumaPt), who discontinued their first TNFi and started a second TNFi between June 2008 and May 2018 were included. Respo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65cf8e58-008f-5b71-9aec-bb25b9762219
DOI
10.21203/rs.3.rs-25511/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?DOI 10.21203/rs.3.rs-25511/v2
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritisSemantic proximity
Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss Clinical Quality Management cohortSemantic proximity
Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registrySemantic proximity
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomySemantic proximity
Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment.Semantic proximity
Continuous effectiveness and safety after a hospital-wide switch to adalimumab biosimilar: an observational study in rheumatoid arthritis patientsSemantic proximity
Self-perceived general health at start of TNFi therapy predicts therapeutic response in patients with rheumatoid arthritis: analysis from the ATTRA registrySemantic proximity
Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort studySemantic proximity
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databasesSemantic proximity
The impact of TNF inhibitors on glucocorticoid use among patients with inflammatory arthritides: A nationwide cohort studySemantic proximity
Differences and Similarities in Clinical and Functional Responses Among Patients Receiving Tofacitinib Monotherapy, Tofacitinib Plus Methotrexate, and Adalimumab Plus Methotrexate: A Post-hoc Analysis of Data From Oral StrategySemantic proximity
The Aftermath of Tapering Tocilizumab After Achieving Treatment Target In Patients With Rheumatoid Arthritis: A Nationwide Cohort StudySemantic proximity
Select a neighboring publication to make it the new centre.